Annotation Detail for AHRR
Basic Information Top
Gene Symbol: | AHRR ( AHH,AHHR,KIAA1234,MGC167813,MGC176630,bHLHe77 ) |
---|---|
Gene Full Name: | aryl-hydrocarbon receptor repressor |
Band: | 5p15.33 |
Quick Links | Entrez ID:57491; OMIM: 606517; Uniprot ID:AHRR_HUMAN; ENSEMBL ID: ENSG00000063438; HGNC ID: 346 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of AHRR mRNA | increases expression | 19933214 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA | increases expression | 16519320 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA | increases expression | 17291011 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | 4-nonylphenol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17291011 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17291011 |
C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in increased expression of AHRR mRNA | increases expression | 19901195 |
C041594 | 4-nonylphenol | [4-nonylphenol co-treated with fulvestrant] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 17291011 |
C041594 | 4-nonylphenol | 4-nonylphenol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17291011 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17291011 |
C508838 | annomontine | annomontine results in increased expression of AHRR mRNA | increases expression | 20449727 |
D001115 | Arecoline | Arecoline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17234337 |
D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of AHRR mRNA | increases expression | 14551997 |
D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of AHRR mRNA | increases expression | 12520768 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 18164116 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of AHRR mRNA | increases expression | 20106945 20064835 19879285 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of AHRR mRNA | increases expression | 16519320 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the expression of AHRR mRNA | affects expression | 20127859 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AHRR mRNA | decreases expression | 19150397 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of AHRR mRNA | increases expression | 20382639 |
C006780 | bisphenol A | bisphenol A results in increased expression of AHRR mRNA | increases expression | 16284450 |
D002243 | Carbolines | Carbolines analog results in increased expression of AHRR mRNA | increases expression | 20449727 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 18164116 |
D004147 | Dioxins | AHRR gene polymorphism results in increased susceptibility to Dioxins | increases response to substance | 15758562 15474075 |
D004147 | Dioxins | AHRR protein polymorphism results in increased susceptibility to Dioxins | increases response to substance | 11835227 |
D004967 | Estrogens | Estrogens inhibits the reaction [AHRR protein results in increased expression of CYP1A1 mRNA] | decreases reaction|increases expression | 15597882 |
D004967 | Estrogens | Estrogens results in increased activity of AHRR protein | increases activity | 15597882 |
C070081 | fulvestrant | [4-nonylphenol co-treated with fulvestrant] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 17291011 |
D017313 | Fenretinide | Fenretinide results in increased expression of AHRR mRNA | increases expression | 16467112 |
C072105 | KN 93 | KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 18089838 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of AHRR mRNA | increases expression | 14672759 12655030 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of AHRR mRNA | increases expression | 9887096 11423533 |
D008748 | Methylcholanthrene | [Tetradecanoylphorbol Acetate co-treated with Methylcholanthrene] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 11423533 |
C058346 | N-(4-methoxyphenyl)retinamide | N-(4-methoxyphenyl)retinamide results in increased expression of AHRR mRNA | increases expression | 16467112 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of AHRR mRNA | decreases expression | 17599377 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased expression of AHRR mRNA | increases expression | 11742002 |
D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of AHRR mRNA | increases expression | 12655030 |
C028632 | rutecarpine | rutecarpine results in increased expression of AHRR mRNA | increases expression | 20449727 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 20055451 |
D013749 | Tetrachlorodibenzodioxin | AHRR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR1 protein] | decreases reaction|increases activity | 11742002 |
D013749 | Tetrachlorodibenzodioxin | AHRR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR2 protein] | decreases reaction|increases activity | 11742002 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 11742002 |
D013749 | Tetrachlorodibenzodioxin | Arecoline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 17234337 |
D013749 | Tetrachlorodibenzodioxin | KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA] | decreases reaction|increases expression | 18089838 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 12655030 20106945 16426572 17234337 17517823 18089838 17599377 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of AHRR mRNA | affects binding|increases expression | 16214954 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 20159946 16102516 14575644 17035482 17975115 12520768 15591033 15652763 16120747 19933214 16556773 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 15664428 15013435 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA | increases expression | 17069994 18990726 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Methylcholanthrene] results in increased expression of AHRR mRNA | affects cotreatment|increases expression | 11423533 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of AHRR mRNA | increases expression | 11423533 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.64 | 11752688 15322242 14514962 | |
MESH:D055371 | Acute Lung Injury | Oxygen | 4.34 | 16759491 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 4.47 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Fenretinide | 4.47 | 10697514 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 15.03 | 6695378 | |
MESH:D000236 | Adenoma | beta-Naphthoflavone | 15.03 | 19389873 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 15.03 | 6695378 10737359 | |
MESH:D000236 | Adenoma | Methylcholanthrene | 15.03 | 6695378 10545420 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 9.35 | 19052882 17620307 17162532 19061943 16434500 18056438 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.35 | 16835633 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.76 | 11748828 | |
MESH:D000860 | Anoxia | Oxygen | 4.84 | 20872349 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.87 | 19183758 | |
MESH:D050197 | Atherosclerosis | Methylcholanthrene | 6.75 | 11922910 | |
MESH:D050197 | Atherosclerosis | Oxygen | 6.75 | 16391483 | |
MESH:D001284 | Atrophy | fulvestrant | 4.65 | 11514358 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 2.86 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.58 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.63 | 15746008 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.67 | 11985600 | |
MESH:D001932 | Brain Neoplasms | Fenretinide | 4.17 | 16187019 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 4.56 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 4.56 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 4.56 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Fenretinide | 4.56 | 16601279 | |
MESH:D001943 | Breast Neoplasms | fulvestrant | 4.56 | 18984771 | |
MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 4.56 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Oxygen | 4.56 | 17263869 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 4.56 | 20435547 | |
MESH:D002277 | Carcinoma | Methylcholanthrene | 7.79 | 10545420 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 7.79 | 16835633 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 4.71 | 3581430 16288022 20084675 21159647 19919837 17428255 16830150 17978847 18785209 17138121 18971187 20935162 20514400 19822196 16878318 11831363 19394651 20007298 18665156 18506893 17055752 17173139 16681979 19171122 20512989 16779866 18788625 20524982 18978308 19701751 16540662 19208518 19107877 16328049 19383236 16502159 10672840 19052882 18494052 18210153 19418558 18393292 18691550 16569478 16698587 20727157 17162532 16935385 19335982 19539802 10737359 3084413 19519916 20214788 18056438 17761372 16807293 20101231 20432363 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 4.71 | 15341023 | |
MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 4.71 | 16270382 17159502 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.78 | 17123778 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 7.34 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 7.34 | 16274795 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 7.34 | 18922899 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.25 | 18850075 18670907 16120746 | |
MESH:D002318 | Cardiovascular Diseases | Dioxins | 5.01 | 19057694 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 10.45 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 10.45 | 17174075 7505956 21159647 2727394 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 10.45 | 16192471 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 5.26 | 16154183 | |
MESH:D054506 | Chloracne | Dioxins | 4.97 | 18329192 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 8.74 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.74 | 16835633 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 2.02 | 16354765 12621046 8697196 15668235 15340226 | |
MESH:D015179 | Colorectal Neoplasms | Fenretinide | 3.07 | 17273769 | |
MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 3.07 | 15531428 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.88 | 14669216 17141729 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 1.25 | 10048152 20055451 15322242 | |
MESH:D016638 | Critical Illness | Estrogens | 5.73 | 16670151 | |
MESH:D003704 | Dementia | Polychlorinated Biphenyls | 4.51 | 16140633 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 4.04 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 4.04 | 17107852 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 3.53 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 3.53 | 20420201 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.61 | 11462148 | |
MESH:D004417 | Dyspnea | Oxygen | 4.62 | 20016425 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 6.33 | 12711302 11000095 | |
MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 6.33 | 8273558 7812673 15177302 9599246 11698051 16716910 8113982 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.69 | 15322242 18230668 16714409 | |
MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 3.98 | 19148513 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.84 | 9294722 10568697 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.90 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 4.16 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 4.16 | 16530937 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.86 | 11564622 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 3.00 | 20387270 21071580 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.25 | 11858732 | |
MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 4.73 | 14633661 10962813 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 2.74 | 20067830 | |
MESH:D005739 | Gas Poisoning | Oxygen | 5.01 | 20016425 | |
MESH:D005909 | Glioblastoma | Fenretinide | 3.76 | 16187019 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.38 | 10696789 | |
MESH:D006330 | Heart Defects, Congenital | 3,4,3',4'-tetrachlorobiphenyl | 10.69 | 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 10.69 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 10.69 | 10048152 11294989 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.15 | 11000095 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.69 | 15340226 12621046 16120746 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.83 | 15340226 16354765 8697196 18606429 16959395 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 1.83 | 18670907 18850075 | |
MESH:D007248 | Infertility, Male | fulvestrant | 3.61 | 11514358 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 7.73 | 18785209 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 7.73 | 12878042 12200463 | |
MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 7.73 | 7562506 8273558 7812673 15177302 11698051 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 3.15 | 16393666 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 3.15 | 16580747 | |
MESH:D007972 | Leukoplakia, Oral | Fenretinide | 5.83 | 16707609 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 2.71 | 20032147 19638242 18522880 18407596 18665156 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 1.23 | 12878042 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 2.05 | 17034775 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 10.04 | 21137059 20195826 | |
MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 10.04 | 19389873 21295105 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 10.04 | 15175105 21071580 19254457 21167192 19690152 2422723 20101389 19090486 18648771 19642983 18754104 19850985 20452335 20118626 19426721 21047994 18644402 2862719 18977376 20501860 19294768 18978307 19812893 19551842 20137499 20583210 19833225 15885732 19256749 19996281 21278145 19255062 12112319 20405173 19638242 20434301 12771043 10737359 16942905 20492335 19073162 19499222 19427195 9163691 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 10.04 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 17.30 | 18164116 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 17.30 | 2563599 18079962 17854601 18544905 19539802 3124819 19004024 18253720 19009564 18093689 21159647 18775883 16842330 19126423 16267830 18164116 18282651 17942915 19519916 18308698 9362446 17174075 | |
MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 17.30 | 1399818 598648 | |
MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 17.30 | 1423854 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 17.30 | 12151625 | |
MESH:D055370 | Lung Injury | Oxygen | 4.30 | 18339021 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 8.22 | 20135361 20869020 18816296 17053015 6695378 18520028 18569708 20064080 20464547 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 8.22 | 21163286 20970405 6695378 20512841 | |
MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 8.22 | 16271038 6695378 20970405 1399818 21163286 10545420 17909032 11893704 16337739 15390079 7750092 9230183 20512841 | |
MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 8.22 | 10814675 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 8.22 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 8.22 | 11807781 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 6.17 | 10697514 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 6.17 | 8985016 | |
MESH:D008545 | Melanoma | Fenretinide | 2.80 | 16270382 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 8.25 | 16381670 | |
MESH:D009062 | Mouth Neoplasms | Fenretinide | 8.25 | 16274795 | |
MESH:D017202 | Myocardial Ischemia | Dioxins | 9.08 | 19057694 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 9.08 | 12213967 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 2.48 | 3581430 9029167 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 4.98 | 11141357 | |
MESH:D009369 | Neoplasms | Fenretinide | 4.98 | 15958647 17353921 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 8.91 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 8.91 | 14600291 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 3.17 | 20387270 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.90 | 20387270 | |
MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 5.47 | 16303764 | |
MESH:D009914 | Oral Submucous Fibrosis | Arecoline | 5.82 | 16311067 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.78 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | Fenretinide | 3.17 | 16133793 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 8.37 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 8.37 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 8.37 | 15976015 | |
MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 4.09 | 12065085 18404319 18922899 8330346 | |
MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 3.32 | 16702228 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.04 | 12520081 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.36 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 3.38 | 2563599 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 8.81 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 8.81 | 11118676 11399792 11896295 11222880 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 4.02 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.19 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 2.19 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Fenretinide | 2.19 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 2.19 | 15721890 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 4.57 | 10548101 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 4.31 | 17627322 18339021 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.64 | 18990726 | |
MESH:D012162 | Retinal Degeneration | Fenretinide | 4.25 | 16303925 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 16.93 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Fenretinide | 16.93 | 16467112 | |
MESH:D012878 | Skin Neoplasms | N-(4-methoxyphenyl)retinamide | 16.93 | 16467112 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 16.93 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 16.93 | 8985016 11807781 8330346 12065085 18404319 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 2.28 | 2093021 20155912 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 2.28 | 18456281 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.77 | 16045194 16684133 | |
MESH:D013398 | Sudden Infant Death | Oxygen | 5.33 | 12563064 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.69 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 2.83 | 7505956 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 5.07 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 5.07 | 16720286 | |
MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 4.38 | 16154183 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 4.80 | 14652134 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.38 | 12125929 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.04 | 15886252 | |
MESH:D014947 | Wounds and Injuries | Estrogens | 4.57 | 11172683 |
No data |